PCRX Pacira BioSciences

• None no insider bought on the open market
• $11K sold by 1 insider outside a trading plan
• $2.7M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Lauren Riker Senior Vice President, Finance
   Planned sale
   $218K 6,000 shares at $36.32 8.8% of stake
   Traded Oct 8 Filed Oct 9
   ↗
3. Jonathan Slonin Chief Medical Officer
   Planned sale
   $71K 3,040 shares at $23.23 1.4% of stake
   Traded Aug 17 Filed Aug 18
   ↗
4. Lauren Riker Senior Vice President, Finance
   Planned sale
   $144K 6,115 shares at $23.50 8.9% of stake
   Traded Jun 11 Filed Jun 12
   ↗
5. Kristen Williams Chief Administrative Officer
   Planned sale
   $228K 10,259 shares at $22.27 5.8% of stake
   Traded Jun 4 Filed Jun 5
   ↗
6. Shawn Cross CFO
   Planned sale
   $326K 12,941 shares at $25.16 11% of stake
   Traded Apr 23 Filed Apr 24
   ↗
7. Shawn Cross CFO
   Planned sale
   $303K 12,059 shares at $25.09 10% of stake
   Traded Apr 20–22 Filed Apr 22
   ↗
8. Jonathan Slonin Chief Medical Officer
   Planned sale
   $74K 3,261 shares at $22.82 1.4% of stake
   Traded Mar 17 Filed Mar 19
   ↗
9. Mark Froimson Director
   Sale
   $11K 500 shares at $21.81 2.4% of stake
   Traded Mar 17 Filed Mar 19
   ↗
10. Lauren Riker Senior Vice President, Finance
    Planned sale
    $83K 4,000 shares at $20.81 7.1% of stake
    Traded Feb 2 Filed Feb 3
    ↗
11. Kristen Williams Chief Administrative Officer
    Planned sale
    $270K 13,137 shares at $20.53 9.1% of stake
    Traded Feb 2 Filed Feb 3
    ↗
12. Lauren Riker Senior Vice President, Finance
    Planned sale
    $34K 1,416 shares at $24.24 2.3% of stake
    Traded Jan 5 Filed Jan 6
    ↗
13. Shawn Cross CFO
    Planned sale
    $627K 25,000 shares at $25.07 31% of stake
    Traded Dec 9–10 Filed Dec 11, 2025
    ↗
14. Jonathan Slonin Chief Medical Officer
    Planned sale
    $95K 3,960 shares at $24.09 2.2% of stake
    Traded Nov 17, 2025 Filed Nov 19, 2025
    ↗
15. Shawn Cross CFO
    Planned sale
    $266K 12,060 shares at $22.09 18% of stake
    Traded Nov 10, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 12 share withholdings for taxes, and 7 option exercises.